» Articles » PMID: 8663540

Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1996 Jul 26
PMID 8663540
Citations 320
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix transcription factor that regulates hypoxia-inducible genes including the human erythropoietin (EPO) gene. In this study, we report structural features of the HIF-1alpha subunit that are required for heterodimerization, DNA binding, and transactivation. The HIF-1alpha and HIF-1beta (ARNT; aryl hydrocarbon receptor nuclear translocator) subunits were coimmunoprecipitated from nuclear extracts, indicating that these proteins heterodimerize in the absence of DNA. In vitro-translated HIF-1alpha and HIF-1beta generated a HIF-1/DNA complex with similar electrophoretic mobility and sequence specificity as HIF-1 present in nuclear extracts from hypoxic cells. Compared to 826-amino acid, full-length HIF-1alpha, amino acids 1-166 mediated heterodimerization with HIF-1beta (ARNT), but amino acids 1-390 were required for optimal DNA binding. A deletion involving the basic domain of HIF-1alpha eliminated DNA binding without affecting heterodimerization. In cotransfection assays, forced expression of recombinant HIF-1alpha and HIF-1beta (ARNT) activated transcription of reporter genes containing EPO enhancer sequences with intact, but not mutant, HIF-1 binding sites. Deletion of the carboxy terminus of HIF-1alpha (amino acids 391-826) markedly decreased the ability of recombinant HIF-1 to activate transcription. Overexpression of a HIF-1alpha construct with deletions of the basic domain and carboxy terminus blocked reporter gene activation by endogenous HIF-1 in hypoxic cells.

Citing Articles

HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.

Shi Y, Gilkes D Cell Mol Life Sci. 2025; 82(1):44.

PMID: 39825916 PMC: 11741981. DOI: 10.1007/s00018-024-05537-0.


Extrinsic and Cell-Intrinsic Stress in the Immune Tumor Micro-Environment.

Ummarino A, Cala N, Allavena P Int J Mol Sci. 2024; 25(22).

PMID: 39596467 PMC: 11594858. DOI: 10.3390/ijms252212403.


Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer's Disease: Beneficial or Detrimental?.

Lin T, Huang C, Lin K, Hsieh Y, Chen S, Lin Y Antioxidants (Basel). 2024; 13(11).

PMID: 39594520 PMC: 11591038. DOI: 10.3390/antiox13111378.


Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells.

Goldmann O, Medina E Front Immunol. 2024; 15:1461455.

PMID: 39534601 PMC: 11554506. DOI: 10.3389/fimmu.2024.1461455.


Targeting Hypoxia and HIF1α in Triple-Negative Breast Cancer: New Insights from Gene Expression Profiling and Implications for Therapy.

Han D, Li Z, Luo L, Jiang H Biology (Basel). 2024; 13(8).

PMID: 39194515 PMC: 11351882. DOI: 10.3390/biology13080577.